Skip to main content

Animations

MJFF Publications

2211 - 2220 of 8571 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2013
  • 2018
  • 2023
  • 2016
  • 2019
  • Summary Details
    OPEN
    Title: Elucidating the importance and regulation of key enhancers for human MEIS1 expression
    Journal Name: Leukemia
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41375-022-01602-4
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: From the prodromal stage of multiple sclerosis to disease prevention
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-022-00686-x
    Best OA location URL:
    Citation Count: 24
  • Summary Details
    RESTRICTED
    Title: The potential utility of smell testing to screen for neurodegenerative disorders
    Journal Name: Expert Review of Molecular Diagnostics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737159.2022.2037424
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Investigational therapeutics for the treatment of progressive supranuclear palsy
    Journal Name: Expert Opinion on Investigational Drugs
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/13543784.2022.2087179
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.06.020
    Citation Count: 206
  • Summary Details
    RESTRICTED
    Title: Pharmacological interventions for psychosis in Parkinson’s disease patients
    Journal Name: Expert Opinion on Pharmacotherapy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14656566.2018.1445721
    Best OA location URL:
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: The Endo-lysosomal System in Parkinson’s Disease: Expanding the Horizon
    Journal Name: Journal of Molecular Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jmb.2023.168140
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Gene therapy to target ER stress in brain diseases
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.064
    Best OA location URL:
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.